Search research articles
Contact Us
Filters
Showing results (191-200 of 229) with videos related to
Page
of 23
Sort By:
Nature
|
December 27, 2006
Early events in the thymus affect the balance of effector and regulatory T cells
Daniel J Pennington, Bruno Silva-Santos, Tobias Silberzahn, et al.
Nature Immunology
|
April 5, 2016
TCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets
Miguel Muñoz-Ruiz, Julie C Ribot, Ana R Grosso, et al.
Plos One
|
August 14, 2008
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression
Boye S Nielsen, Mikala Egeblad, Fritz Rank, et al.
Cancer Research Communications
|
March 22, 2024
Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate
Priyanka Hirani, Jacqueline McDermott, Vinothini Rajeeve, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 23, 2003
Determinants of human B cell migration across brain endothelial cells
Andrea Alter, Martin Duddy, Sherry Hebert, et al.
British Journal of Cancer
|
February 9, 2006
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
M J Wallard, C J Pennington, A Veerakumarasivam, et al.
Nature Immunology
|
March 10, 2009
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets
Julie C Ribot, Ana deBarros, Dick John Pang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2010
Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks
Justin A Green, Paul T Elkington, Caroline J Pennington, et al.
Breast Cancer Research : BCR
|
May 2, 2009
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
Rachael A Hancox, Michael D Allen, Deborah L Holliday, et al.
Cancer Research
|
July 29, 2010
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases
Jennifer M Atkinson, Robert A Falconer, Dylan R Edwards, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 229) with videos related to
Sort By:
Page
of 23
Nature
|
December 27, 2006
Early events in the thymus affect the balance of effector and regulatory T cells
Daniel J Pennington, Bruno Silva-Santos, Tobias Silberzahn, et al.
Nature Immunology
|
April 5, 2016
TCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets
Miguel Muñoz-Ruiz, Julie C Ribot, Ana R Grosso, et al.
Plos One
|
August 14, 2008
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression
Boye S Nielsen, Mikala Egeblad, Fritz Rank, et al.
Cancer Research Communications
|
March 22, 2024
Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate
Priyanka Hirani, Jacqueline McDermott, Vinothini Rajeeve, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 23, 2003
Determinants of human B cell migration across brain endothelial cells
Andrea Alter, Martin Duddy, Sherry Hebert, et al.
British Journal of Cancer
|
February 9, 2006
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
M J Wallard, C J Pennington, A Veerakumarasivam, et al.
Nature Immunology
|
March 10, 2009
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets
Julie C Ribot, Ana deBarros, Dick John Pang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2010
Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks
Justin A Green, Paul T Elkington, Caroline J Pennington, et al.
Breast Cancer Research : BCR
|
May 2, 2009
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
Rachael A Hancox, Michael D Allen, Deborah L Holliday, et al.
Cancer Research
|
July 29, 2010
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases
Jennifer M Atkinson, Robert A Falconer, Dylan R Edwards, et al.
Page
of 23